UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities and Exchange Act of 1934

Inverness Medical Innovations Inc.
(Name of Issuer)

Common Stock, $0.001 par value
(Title of Class of Securities)

46126P106
(CUSIP Number)

Allison Bennington, Esq.
ValueAct Capital
435 Pacific Avenue, Fourth Floor
San Francisco, CA 94133
(415) 362-3700
(Name, address and telephone number of Person
Authorized to Receive Notices and Communications)

Christopher G. Karras, Esq.
Dechert LLP
Cira Centre
2929 Arch Street
Philadelphia, PA 19104-2808
(215) 994-4000

April 21, 2010
(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box [ ].

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 240.13d-7 for other parties to whom copies are to be sent.

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

This information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


SCHEDULE 13D

-------------------------- -------------------------
CUSIP NO. 46126P106 Page 2 of 13
-----------------------------------------------------------------------------
1. NAME OF REPORTING PERSON/S.S. OR I.R.S. INDENTIFICATION NO. OF ABOVE
 PERSON (entities only)

 ValueAct Capital Master Fund, L.P.
-----------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X]
 (b) [ ]
-----------------------------------------------------------------------------
3. SEC USE ONLY

-----------------------------------------------------------------------------
4. SOURCE OF FUNDS (See Instructions)*

 WC*
-----------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
 PURSUANT TO ITEMS 2(d) or 2(e) [ ]
-----------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION

 British Virgin Islands
-----------------------------------------------------------------------------
 7. SOLE VOTING POWER
 0
 NUMBER OF ----------------------------------------------------------
 SHARES 8. SHARED VOTING POWER
 BENEFICIALLY 4,563,782**
 OWNED BY EACH ----------------------------------------------------------
 PERSON WITH 9. SOLE DISPOSITIVE POWER
 0
 ----------------------------------------------------------
 10. SHARED DISPOSITIVE POWER
 4,563,782**
-----------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 4,563,782**
-----------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
 CERTAIN SHARES [ ]
-----------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 5.4%
-----------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON

 PN
-----------------------------------------------------------------------------
*See Item 3
**See Item 2 and 5


SCHEDULE 13D

-------------------------- -------------------------
CUSIP NO. 46126P106 Page 3 of 13
----------------------------------------------------------------------------
1. NAME OF REPORTING PERSON/S.S. OR I.R.S. INDENTIFICATION NO. OF ABOVE
 PERSON (entities only)

 VA Partners I, LLC
-----------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X]
 (b) [ ]
-----------------------------------------------------------------------------
3. SEC USE ONLY

-----------------------------------------------------------------------------
4. SOURCE OF FUNDS*

 00*
-----------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
 PURSUANT TO ITEMS 2(d) or 2(e) [ ]
-----------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION

 Delaware
-----------------------------------------------------------------------------
 7. SOLE VOTING POWER
 0
 NUMBER OF ----------------------------------------------------------
 SHARES 8. SHARED VOTING POWER
 BENEFICIALLY 4,563,782**
 OWNED BY EACH ----------------------------------------------------------
 PERSON WITH 9. SOLE DISPOSITIVE POWER
 0
 ----------------------------------------------------------
 10. SHARED DISPOSITIVE POWER
 4,563,782**
-----------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 4,563,782**
-----------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
 CERTAIN SHARES [ ]
-----------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 5.4%
-----------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON

 00 (LLC)
-----------------------------------------------------------------------------
*See Item 3
**See Item 2 and 5


SCHEDULE 13D

-------------------------- -------------------------
CUSIP NO. 46126P106 Page 4 of 13
----------------------------------------------------------------------------
1. NAME OF REPORTING PERSON/S.S. OR I.R.S. INDENTIFICATION NO. OF ABOVE
 PERSON (entities only)

 ValueAct Capital Management, L.P.
-----------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X]
 (b) [ ]
-----------------------------------------------------------------------------
3. SEC USE ONLY

-----------------------------------------------------------------------------
4. SOURCE OF FUNDS*

 00*
-----------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
 PURSUANT TO ITEMS 2(d) or 2(e) [ ]
-----------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION

 Delaware
-----------------------------------------------------------------------------
 7. SOLE VOTING POWER
 0
 NUMBER OF ----------------------------------------------------------
 SHARES 8. SHARED VOTING POWER
 BENEFICIALLY 4,563,782**
 OWNED BY EACH ----------------------------------------------------------
 PERSON WITH 9. SOLE DISPOSITIVE POWER
 0
 ----------------------------------------------------------
 10. SHARED DISPOSITIVE POWER
 4,563,782**
-----------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 4,563,782**
-----------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
 CERTAIN SHARES [ ]
-----------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 5.4%
-----------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON

 PN
-----------------------------------------------------------------------------
*See Item 3
**See Item 2 and 5


SCHEDULE 13D

-------------------------- -------------------------
CUSIP NO. 46126P106 Page 5 of 13
----------------------------------------------------------------------------
1. NAME OF REPORTING PERSON/S.S. OR I.R.S. INDENTIFICATION NO. OF ABOVE
 PERSON (entities only)

 ValueAct Capital Management, LLC
-----------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X]
 (b) [ ]
-----------------------------------------------------------------------------
3. SEC USE ONLY

-----------------------------------------------------------------------------
4. SOURCE OF FUNDS*

 00*
-----------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
 PURSUANT TO ITEMS 2(d) or 2(e) [ ]
-----------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION

 Delaware
-----------------------------------------------------------------------------
 7. SOLE VOTING POWER
 0
 NUMBER OF ----------------------------------------------------------
 SHARES 8. SHARED VOTING POWER
 BENEFICIALLY 4,563,782**
 OWNED BY EACH ----------------------------------------------------------
 PERSON WITH 9. SOLE DISPOSITIVE POWER
 0
 ----------------------------------------------------------
 10. SHARED DISPOSITIVE POWER
 4,563,782**
-----------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 4,563,782**
-----------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
 CERTAIN SHARES [ ]
-----------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 5.4%
-----------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON

 00 (LLC)
-----------------------------------------------------------------------------
*See Item 3
**See Item 2 and 5


SCHEDULE 13D

-------------------------- -------------------------
CUSIP NO. 46126P106 Page 6 of 13
-----------------------------------------------------------------------------
1. NAME OF REPORTING PERSON/S.S. OR I.R.S. INDENTIFICATION NO. OF ABOVE
 PERSON (entities only)

 ValueAct Holdings, L.P.
---------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X]
 (b) [ ]
-----------------------------------------------------------------------------
3. SEC USE ONLY

---------------------------------------------------------------------------
4. SOURCE OF FUNDS*

 00*
-----------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
 PURSUANT TO ITEMS 2(d) or 2(e) [ ]
-----------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION

 Delaware
-----------------------------------------------------------------------------
 7. SOLE VOTING POWER
 0
 NUMBER OF ----------------------------------------------------------
 SHARES 8. SHARED VOTING POWER
 BENEFICIALLY 4,563,782**
 OWNED BY EACH ----------------------------------------------------------
 PERSON WITH 9. SOLE DISPOSITIVE POWER
 0
 ----------------------------------------------------------
 10. SHARED DISPOSITIVE POWER
 4,563,782**
-----------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 4,563,782**
-----------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
 CERTAIN SHARES [ ]
-----------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 5.4%
-----------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON

 PN
-----------------------------------------------------------------------------
*See Item 3
**See Items 2 and 5


SCHEDULE 13D

-------------------------- -------------------------
CUSIP NO. 46126P106 Page 7 of 13
-----------------------------------------------------------------------------
1. NAME OF REPORTING PERSON/S.S. OR I.R.S. INDENTIFICATION NO. OF ABOVE
 PERSON (entities only)

 ValueAct Holdings GP, LLC
---------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X]
 (b) [ ]
-----------------------------------------------------------------------------
3. SEC USE ONLY

-----------------------------------------------------------------------------
4. SOURCE OF FUNDS*

 00*
-----------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
 PURSUANT TO ITEMS 2(d) or 2(e) [ ]
-----------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION

 Delaware
-----------------------------------------------------------------------------
 7. SOLE VOTING POWER
 0
 NUMBER OF ----------------------------------------------------------
 SHARES 8. SHARED VOTING POWER
 BENEFICIALLY 4,563,782**
 OWNED BY EACH ----------------------------------------------------------
 PERSON WITH 9. SOLE DISPOSITIVE POWER
 0
 ----------------------------------------------------------
 10. SHARED DISPOSITIVE POWER
 4,563,782**
-----------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 4,563,782**
-----------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
 CERTAIN SHARES [ ]
-----------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 5.4%
-----------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON

 00 (LLC)
-----------------------------------------------------------------------------
*See Item 3
**See Items 2 and 5


-------------------------- -------------------------
CUSIP NO. 46126P106 Page 8 of 13
-----------------------------------------------------------------------------
Item 1. Security and Issuer

 This Schedule 13D relates to the Common Stock, $0.001 par value per
share (the "Common Stock of Inverness Medical Innovations Inc., a Delaware
corporation (the "Issuer"). The address of the principal executive offices
of the Issuer is 51 Sawyer Road, Suite 200, Waltham, Massachusetts 02453.

Item 2. Identity and Background

 This statement is filed jointly by (a) ValueAct Capital Master Fund,
L.P. ("ValueAct Master Fund"), (b) VA Partners I, LLC ("VA Partners I"), (c)
ValueAct Capital Management, L.P. ("ValueAct Management L.P."), (d) ValueAct
Capital Management, LLC ("ValueAct Management LLC"), (e) ValueAct Holdings,
L.P. ("ValueAct Holdings") and (f) ValueAct Holdings GP, LLC ("ValueAct
Holdings GP")(collectively, the "Reporting Persons").

 ValueAct Master Fund is a limited partnership organized under the laws
of the British Virgin Islands. It has a principal business address of 435
Pacific Avenue, Fourth Floor, San Francisco, CA 94133.

 VA Partners I is a Delaware limited liability company, the principal
business of which is to serve as the General Partner to ValueAct Master Fund.
It has a principal business address of 435 Pacific Avenue, Fourth Floor, San
Francisco, CA 94133.

 ValueAct Management L.P. is a Delaware limited partnership which
renders management services to ValueAct Master Fund. ValueAct Management LLC
is a Delaware limited liability company, the principal business of which is
to serve as the General Partner to ValueAct Management L.P. Each has a
principal business address of 435 Pacific Avenue, Fourth Floor, San
Francisco, CA 94133.

 ValueAct Holdings is a Delaware limited partnership and is the sole
owner of the limited partnership interests of ValueAct Management L.P. and
the membership interests of ValueAct Management LLC and is the majority owner
of the membership interests of VA Partners I. ValueAct Holdings GP is a
Delaware limited liability company, the principal business of which is to
serve as the General Partner to ValueAct Holdings. Each has a principal
business address of 435 Pacific Avenue, Fourth Floor, San Francisco, CA
94133.

 (d) and (e). None of the entities or persons identified in this Item 2
has during the past five years been convicted of any criminal proceeding
(excluding traffic violations or similar misdemeanors), nor been a party to a
civil proceeding of a judicial or administrative body of competent judgment,
decree or final order enjoining future violations of, or prohibiting or
mandating activities subject to, federal or state securities laws or finding
any violation with respect to such laws.

Item 3. Source and Amount of Funds or Other Consideration

 The source of funds used for the purchase of the Issuer's securities
was the working capital of ValueAct Master Fund. The aggregate funds used by
these Reporting Persons to make the purchases were $43,677,040.00.


-------------------------- -------------------------
CUSIP NO. 46126P106 Page 9 of 13
-----------------------------------------------------------------------------

Item 4. Purpose of Transaction

 The Reporting Persons have acquired the Issuer's Common Stock for
investment purposes, and such purchases have been made in the Reporting
Persons' ordinary course of business.

 In pursuing such investment purposes, the Reporting Persons may further
purchase, hold, vote, trade, dispose or otherwise deal in the Common Stock at
times, and in such manner, as they deem advisable to benefit from changes in
market prices of such Common Stock, changes in the Issuer's operations,
business strategy or prospects, or from sale or merger of the Issuer. To
evaluate such alternatives, the Reporting Persons will routinely monitor the
Issuer's operations, prospects, business development, management, competitive
and strategic matters, capital structure, and prevailing market conditions,
as well as alternative investment opportunities, liquidity requirements of
the Reporting Persons and other investment considerations. Consistent with
its investment research methods and evaluation criteria, the Reporting
Persons may discuss such matters with management or directors of the Issuer,
other shareholders, industry analysts, existing or potential strategic
partners or competitors, investment and financing professionals, sources of
credit and other investors. Such factors and discussions may materially
affect, and result in, the Reporting Persons' modifying their ownership of
Common Stock, exchanging information with the Issuer pursuant to appropriate
confidentiality or similar agreements, proposing changes in the Issuer's
operations, governance or capitalization, or in proposing one or more of the
other actions described in subsections (a) through (j) of Item 4 of Schedule
13D.

 The Reporting Persons reserve the right to formulate other plans and/or
make other proposals, and take such actions with respect to their investment
in the Issuer, including any or all of the actions set forth in paragraphs
(a) through (j) of Item 4 of Schedule 13D, or acquire additional Common Stock
or dispose of all the Common Stock beneficially owned by them, in the public
market or privately negotiated transactions. The Reporting Persons may at
any time reconsider and change their plans or proposals relating to the
foregoing.

Item 5. Interest in Securities of the Issuer

 (a) and (b). Set forth below is the beneficial ownership of shares of
Common Stock of the Issuer for each person named in Item 2. Shares reported
as beneficially owned by ValueAct Master Fund are also reported as
beneficially owned by (i) ValueAct Management L.P. as the manager of each
such investment partnership, (ii) ValueAct Management LLC, as General Partner
of ValueAct Management L.P., (iii) ValueAct Holdings, as the sole owner of
the limited partnership interests of ValueAct Management L.P. and the
membership interests of ValueAct Management LLC and as the majority owner of
the membership interests of VA Partners I and (iv) ValueAct Holdings GP, as
General Partner of ValueAct Holdings. Shares reported as beneficially owned
by ValueAct Master Fund are also reported as beneficially owned by VA
Partners I, as General Partner of ValueAct Master Fund. VA Partners I,
ValueAct Management L.P., ValueAct Management LLC, ValueAct Holdings and
ValueAct Holdings GP also, directly or indirectly, may own interests in one


-------------------------- -------------------------
CUSIP NO. 46126P106 Page 10 of 13
-----------------------------------------------------------------------------

or more than one of the partnerships from time to time. Unless otherwise
indicated below, by reason of such relationship ValueAct Master Fund is
reported as having shared power to vote or to direct the vote, and shared
power to dispose or direct the disposition of, such shares of Common Stock,
with VA Partners I (only with respect to ValueAct Master Fund), ValueAct
Management L.P., ValueAct Management LLC, ValueAct Holdings and ValueAct
Holdings GP.

 As of the date hereof, ValueAct Master Fund is the beneficial owner
of 4,563,782 shares of Common Stock, representing approximately 5.4% of the
Issuer's outstanding Common Stock (which shares may also be deemed to be
beneficially owned by VA Partners I).

 ValueAct Management L.P., ValueAct Management LLC, ValueAct Holdings
and ValueAct Holdings GP may each be deemed the beneficial owner of an
aggregate of 4,563,782 shares of Common Stock, representing approximately
5.4% of the Issuer's outstanding Common Stock.

 All percentages set forth in this Schedule 13D are based upon the
Issuer's reported 83,964,221 outstanding shares of Common Stock as
reported in the Issuer's Form 10-K/A for the fiscal year ended December
31, 2009.

 (c) In the 60 days prior to this filing, the Reporting Persons
purchased the following shares of Common Stock in the open market:

Reporting Person Trade Date Shares Price/Share
---------------- ---------- --------- -----------
ValueAct Master Fund 04/12/2010 150,000 $38.03
 04/13/2010 100,000 $37.61
 04/14/2010 100,000 $38.00
 04/16/2010 100,000 $38.50
 04/19/2010 100,000 $38.34
 04/20/2010 100,000 $38.64
 04/21/2010 100,000 $38.42
 04/22/2010 150,000 $37.59
 04/23/2010 150,000 $37.49
 04/26/2010 50,000 $37.37
 04/26/2010 50,000 $37.13

 (d) and (e) Not applicable.

Item 6. Contracts, Arrangements, Understandings or Relationships with
 Respect to Securities of the Issuer

 Other than as described elsewhere in this Report and as previously
reported, the Reporting Persons have no understandings, arrangements,
relationships or contracts relating to the Issuer's Common Stock which are
required to be described hereunder.

Item 7. Material to Be Filed as Exhibits

(1) Joint Filing Agreement.


-------------------------- -------------------------
CUSIP NO. 46126P106 Page 11 of 13
-----------------------------------------------------------------------------
 SIGNATURE
 After reasonable inquiry and to the best of his knowledge and
belief, the undersigned certifies that the information set forth in this
statement is true, complete and correct.

 POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears
below on this Schedule 13D hereby constitutes and appoints Jeffrey W. Ubben,
George F. Hamel, Jr., G. Mason Morfit and Allison Bennington, and each of
them, with full power to act without the other, his or its true and lawful
attorney-in-fact and agent, with full power of substitution and
resubstitution, for him or it and in his or its name, place and stead, in any
and all capacities (until revoked in writing) to sign any and all amendments
to this Schedule 13D, and to file the same, with all exhibits thereto and
other documents in connection therewith, with the Securities and Exchange
Commission, granting unto said attorneys-in-fact and agents, and each of
them, full power and authority to do and perform each and every act and thing
requisite and necessary fully to all intents and purposes as he or it might
or could do in person, thereby ratifying and confirming all that said
attorneys-in-fact and agents or any of them, or their or his substitute or
substitutes, may lawfully do or cause to be done by virtue hereof.

 ValueAct Capital Master Fund L.P., by
 VA Partners I, LLC, its General Partner

 By: /s/ George F. Hamel, Jr.
 --------------------------------------
Dated: April 28, 2010 George F. Hamel, Jr., Chief Operating Officer

 VA Partners I, LLC

 By: /s/ George F. Hamel, Jr.
 --------------------------------------
Dated: April 28, 2010 George F. Hamel, Jr., Chief Operating Officer


 ValueAct Capital Management, L.P., by
 ValueAct Capital Management, LLC its
 General Partner

 By: /s/ George F. Hamel, Jr.
 --------------------------------------
Dated: April 28, 2010 George F. Hamel, Jr., Chief Operating Officer


 ValueAct Capital Management, LLC

 By: /s/ George F. Hamel, Jr.
 --------------------------------------
Dated: April 28, 2010 George F. Hamel, Jr., Chief Operating Officer


-------------------------- -------------------------
CUSIP NO. 46126P106 Page 12 of 13
-----------------------------------------------------------------------------


 ValueAct Holdings, L.P., by
 ValueAct Holdings GP, LLC, its
 General Partner

 By: /s/ George F. Hamel, Jr.
 --------------------------------------
Dated: April 28, 2010 George F. Hamel, Jr., Chief Operating Officer


 ValueAct Holdings GP, LLC

 By: /s/ George F. Hamel, Jr.
 --------------------------------------
Dated: April 28, 2010 George F. Hamel, Jr., Chief Operating Officer


-------------------------- -------------------------
CUSIP NO. 46126P106 Page 13 of 13
-----------------------------------------------------------------------------
 Exhibit 1

 JOINT FILING UNDERTAKING

The undersigned parties hereby agree that the Schedule 13D filed herewith
(and any amendments thereto) relating to the Common Stock of Inverness
Medical Innovations Inc., is being filed jointly on behalf of each of them
with the Securities and Exchange Commission pursuant to Section 13(d) of the
Securities Exchange Act of 1934, as amended.

 ValueAct Capital Master Fund L.P., by
 VA Partners I, LLC, its General Partner

 By: /s/ George F. Hamel, Jr.
 --------------------------------------
Dated: April 28, 2010 George F. Hamel, Jr., Chief Operating Officer

 VA Partners I, LLC

 By: /s/ George F. Hamel, Jr.
 --------------------------------------
Dated: April 28, 2010 George F. Hamel, Jr., Chief Operating Officer


 ValueAct Capital Management, L.P., by
 ValueAct Capital Management, LLC its
 General Partner

 By: /s/ George F. Hamel, Jr.
 --------------------------------------
Dated: April 28, 2010 George F. Hamel, Jr., Chief Operating Officer


 ValueAct Capital Management, LLC

 By: /s/ George F. Hamel, Jr.
 --------------------------------------
Dated: April 28, 2010 George F. Hamel, Jr., Chief Operating Officer

 ValueAct Holdings, L.P., by
 ValueAct Holdings GP, LLC, its
 General Partner

 By: /s/ George F. Hamel, Jr.
 --------------------------------------
Dated: April 28, 2010 George F. Hamel, Jr., Chief Operating Officer


 ValueAct Holdings GP, LLC

 By: /s/ George F. Hamel, Jr.
 --------------------------------------
Dated: April 28, 2010 George F. Hamel, Jr., Chief Operating Officer

Alere Inc. Common Stock (NYSE:IMA)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024 Click aqui para mais gráficos Alere Inc. Common Stock.
Alere Inc. Common Stock (NYSE:IMA)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024 Click aqui para mais gráficos Alere Inc. Common Stock.